» Articles » PMID: 38792441

Impact of Fat Distribution and Metabolic Diseases on Cerebral Microcirculation: A Multimodal Study on Type 2 Diabetic and Obese Patients

Overview
Journal J Clin Med
Specialty General Medicine
Date 2024 May 25
PMID 38792441
Authors
Affiliations
Soon will be listed here.
Abstract

: Since metabolic diseases and atherosclerotic vascular events are firmly associated, herein we investigate changes in central microcirculation and atherosclerosis-related body fat distribution in patients with type 2 diabetes mellitus and obesity. Resting brain perfusion single-photon emission computed tomography (SPECT) imaging with Technetium-99m hexamethylpropylene amine oxime ([Tc]Tc-HMPAO SPECT) was performed, and the breath-holding index (BHI) and carotid intima-media thickness (cIMT) were measured to characterise central microcirculation. Besides CT-based abdominal fat tissue segmentation, C-peptide level, glycaemic and anthropometric parameters were registered to search for correlations with cerebral blood flow and vasoreactivity. : Although no significant difference was found between the resting cerebral perfusion of the two patient cohorts, a greater blood flow increase was experienced in the obese after the breath-holding test than in the diabetics ( < 0.05). A significant positive correlation was encountered between resting and provocation-triggered brain perfusion and C-peptide levels ( < 0.005). BMI and cIMT were negatively correlated (rho = -0.27 and -0.23 for maximum and mean cIMT, respectively), while BMI and BHI showed a positive association (rho = 0.31 and rho = 0.29 for maximum and mean BHI, respectively), which could be explained by BMI-dependent changes in fat tissue distribution. cIMT demonstrated a disproportional relationship with increasing age, and higher cIMT values were observed for the men. Overall, C-peptide levels and circulatory parameters seem to be strong applicants to predict brain microvascular alterations and related cognitive decline in such patient populations.

References
1.
Ghorbani A, Shafiee-Nick R . Pathological consequences of C-peptide deficiency in insulin-dependent diabetes mellitus. World J Diabetes. 2015; 6(1):145-50. PMC: 4317306. DOI: 10.4239/wjd.v6.i1.145. View

2.
Guzik A, Bushnell C . Stroke Epidemiology and Risk Factor Management. Continuum (Minneap Minn). 2017; 23(1, Cerebrovascular Disease):15-39. DOI: 10.1212/CON.0000000000000416. View

3.
Selvarajah D, Hughes T, Reeves J, Boland E, Marques J, Gandhi R . A preliminary study of brain macrovascular reactivity in impaired glucose tolerance and type-2 diabetes: Quantitative internal carotid artery blood flow using magnetic resonance phase contrast angiography. Diab Vasc Dis Res. 2016; 13(5):367-72. DOI: 10.1177/1479164116644404. View

4.
Cui Y, Liang X, Gu H, Hu Y, Zhao Z, Yang X . Cerebral perfusion alterations in type 2 diabetes and its relation to insulin resistance and cognitive dysfunction. Brain Imaging Behav. 2016; 11(5):1248-1257. PMC: 5653700. DOI: 10.1007/s11682-016-9583-9. View

5.
Caprio F, Sorond F . Cerebrovascular Disease: Primary and Secondary Stroke Prevention. Med Clin North Am. 2019; 103(2):295-308. DOI: 10.1016/j.mcna.2018.10.001. View